Connection
Alan Gamis to NF-kappa B
This is a "connection" page, showing publications Alan Gamis has written about NF-kappa B.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.209 |
|
|
|
-
van Dijk AD, Hoff FW, Qiu Y, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, Jenkins GN, de Bont ESJM, Kornblau SM, Horton TM. Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-?B subunit RelA. Proteomics Clin Appl. 2022 03; 16(2):e2100072.
Score: 0.209